An LVAD, or left ventricular assist device, is a mechanical pump surgically implanted in the chest to help a weakened heart pump blood to the rest of the body. It does not replace the heart. Instead, it takes over much of the work that the left ventricle, your heart’s main pumping chamber, can no longer do on its own. LVADs are used in people with advanced heart failure whose condition hasn’t improved with medications alone.
How an LVAD Works
The pump is attached to the bottom of the heart, at the tip of the left ventricle. It draws blood from that chamber and pushes it through a tube connected to the aorta, your body’s largest artery, which then delivers blood to your organs and tissues. In a healthy heart, the left ventricle does this work with each beat. In someone with severe heart failure, the muscle is too weak to circulate enough blood, and the LVAD fills that gap.
The most widely used device today, the HeartMate 3, uses a centrifugal-flow rotary pump with a single moving part: a rotor that spins while suspended by magnets inside the blood stream. This magnetic levitation design reduces friction and damage to blood cells compared to earlier pump generations. The device runs continuously, which means many LVAD patients have a weakened or absent pulse, something that surprises people who encounter it for the first time.
Parts of the System
An LVAD isn’t just the pump inside the chest. It’s a system with internal and external components that work together:
- Internal pump: Sits inside the chest, connected to the left ventricle and aorta. This is the only part fully inside the body.
- Driveline: A cable that exits through a small opening in the abdomen, connecting the internal pump to the external controller. This cable is always present and requires careful daily maintenance.
- Controller: A small computer worn outside the body, typically on a belt or harness. It powers the pump, monitors performance, and sounds alarms if something needs attention. It has a small screen and indicator lights that display system status.
- Power sources: Rechargeable batteries for when you’re moving around, and a plug-in power unit for when you’re stationary or sleeping. Batteries provide up to about 14 hours of power depending on the device, and you swap them before they run out.
You are always connected to the controller and a power source. There is no point at which the external equipment can be fully removed.
Who Gets an LVAD
LVADs are reserved for people with advanced heart failure that hasn’t responded to standard medications and other treatments. Typically, candidates have a left ventricular ejection fraction of 25% or lower, meaning the heart is pumping out a quarter or less of the blood in the chamber with each beat. A healthy heart pumps around 55% to 70%.
There are two main reasons someone receives an LVAD. The first is as a bridge to transplant: the device keeps you alive and functioning while you wait for a donor heart. You must be approved and listed as a transplant candidate for this use. The second is destination therapy, where the LVAD is a permanent treatment for people who are not eligible for a heart transplant. In destination therapy, the device is intended to support the heart for the rest of the patient’s life.
The Surgery and Recovery
LVAD implantation is open-heart surgery performed under general anesthesia. The surgeon places the pump at the base of the heart, connects the outflow tube to the aorta, and threads the driveline cable out through the abdomen. Most patients spend four to five days in the ICU afterward while intravenous medications are gradually reduced. The total hospital stay averages 14 to 21 days.
Recovery involves physical and occupational therapy to rebuild strength, along with training on how to manage the device at home. You and a caregiver will learn how to operate the controller, swap batteries, respond to alarms, and care for the driveline exit site. This training is extensive because managing the equipment correctly is essential to preventing complications.
Sternal precautions, meaning restrictions on lifting and upper body movement, last six to eight weeks after surgery to allow the breastbone to heal.
Daily Life With an LVAD
Living with an LVAD requires a consistent daily routine centered on the driveline exit site, where the cable passes through your skin. This opening is a direct path for bacteria to enter the body, so keeping it clean and protected is critical. Most patients clean the site with chlorhexidine and cover it with sterile gauze or a silver-based dressing. While the site is still healing, daily dressing changes are standard. Once fully healed, that frequency can drop to once or twice a week.
An anchoring device holds the driveline in place against the body to prevent tugging or trauma at the exit site. Research has found that keeping this area dry significantly reduces infection risk. One study showed driveline infections dropped from 42% to 14% in patients who kept the site dry rather than exposing it to conventional showers. When you do shower, the area should be protected and the dressing changed immediately afterward.
Some activities are permanently off-limits. Swimming, hot tubs, and baths are not allowed because submerging the driveline exit site in water creates a serious infection risk and could damage the external equipment. Contact sports and jumping are also restricted. That said, many LVAD patients walk, do light exercise, travel, return to work, and maintain active social lives. The device is designed to be portable, and the batteries allow hours of untethered movement.
Risks and Complications
The most common complication is bleeding, occurring in 30% to 60% of patients both early and late after implantation. This high rate stems from a fundamental tension in LVAD management: the device’s artificial surfaces can trigger blood clots, so patients must take blood-thinning medications long-term. These medications reduce the risk of clot-related emergencies but increase the risk of bleeding events.
The most dangerous clot-related complications are pump thrombosis, where a clot forms inside the device itself, and stroke. These carry mortality rates as high as 50%. Patients take a combination of blood thinners to keep their clotting within a specific target range, which requires regular blood testing and dose adjustments.
Driveline infections are the other major ongoing risk. Because the cable permanently exits the skin, there is always a potential entry point for bacteria. Strict exit-site care and the use of anchoring devices and antimicrobial dressings help reduce this risk, but it never fully disappears.
Survival Outcomes
Survival rates have improved dramatically as pump technology has evolved. Older data from patients implanted between 2011 and 2013 in England showed a one-year mortality rate of about 40% and a five-year mortality rate of roughly 59%. But those numbers reflect earlier-generation devices.
With the HeartMate 3, outcomes are substantially better. Data from the ELEVATE Registry, which tracks patients with this newer device, reported a two-year death rate of just 17%. That’s a meaningful shift, driven largely by the pump’s magnetic levitation design, which causes less damage to blood cells and produces fewer clotting complications than its predecessors. For many patients with end-stage heart failure, the LVAD offers years of life that would not otherwise be possible.